StockData
Allarity Therapeutics, Inc. logo

Allarity Therapeutics, Inc. (ALLR) stock

ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.84−0.03 (-3.91%)

Close on Nov 17, 2026Market cap $13.38MP/E –Yield –

Allarity Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Allarity Therapeutics

Allarity Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Allarity Therapeutics figures

See a number that looks wrong?